News

Fatty liver disease, also called metabolic dysfunction-associated steatohepatitis (MASH), is a condition where fat ...
Brigham Buhler, a MAHA influencer and biotech entrepreneur, has Robert F. Kennedy’s ear. But will RFK listen to his call to ...
Q. I took Wegovy for a few months last fall until I was unable to find a pharmacy that could fill my prescription. They were ...
It’s illegal to advertise prescription drugs. Novo Nordisk, which makes Ozempic and Wegovy, has not named any drugs in its ...
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can lead to significant weight loss and improve blood sugar control in ...
Research presented at the the European Congress on Obesity suggests weight loss injections are safe and work for the mentally ...
Novo Nordisk A/S (NYSE: NVO) is seeking FDA approval for the pill version of its obesity drug, Wegovy. The company highlights ...
Investors are worried Novo Nordisk's competition with Eli Lilly is heating up and that the first-to-market GLP-1 leader is ...
Weight Watchers aims to minimize debt with the bankruptcy filing and refocus the business on its telehealth services.
Novo Nordisk A/S' Q1 earnings reveal strong growth in semaglutide-driven sales despite a slight revenue miss. Learn more ...
WeightWatchers is going on a financial diet, aiming to lose $1.15 billion in debt through a fast-track bankruptcy plan.Parent ...